MARSHALL WACE ASIA Ltd - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE ASIA Ltd ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2021$1,305,000
+374.5%
33,243
+241.8%
0.03%
+366.7%
Q1 2021$275,000
-56.9%
9,727
-58.0%
0.01%
-57.1%
Q2 2020$638,000
+6280.0%
23,139
+4169.2%
0.01%
Q1 2020$10,000
-85.9%
542
-86.4%
0.00%
-100.0%
Q3 2019$71,000
-77.8%
3,976
-62.6%
0.00%
-81.8%
Q2 2018$320,00010,6200.01%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GENERAL ATLANTIC, L.P. 4,000,000$67,760,0001.05%
M&G INVESTMENT MANAGEMENT LTD 7,084,834$120,442,1780.54%
Bellevue Group AG 1,802,963$30,584,7610.49%
AIA Group Ltd 391,278$6,628,2490.32%
PLATINUM INVESTMENT MANAGEMENT LTD 182,052$3,083,9610.12%
SCHRODER INVESTMENT MANAGEMENT GROUP 4,219,168$71,472,7060.11%
Hennion & Walsh Asset Management, Inc. 51,735$876,3910.06%
Allianz Asset Management GmbH 1,644,999$27,866,2830.05%
Janney Capital Management LLC 17,203$2910.02%
ACADIAN ASSET MANAGEMENT LLC 193,811$3,2680.01%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders